Physiological functions of carnitine and carnitine transporters in the central nervous system

Japanese Journal of Neuropsychopharmacology

Volumn 28, Issue 3, 2008, Pages 113-120

  Inazu, Masato ^a   Matsumiya, Teruhiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Ketone body; L carnitine; Mitochondria; Organic cation carnitine transporter 2; Transporter

Indexed keywords

CARNITINE; CARRIER PROTEIN; KETONE BODY; LEVACECARNINE; ORGANIC CATION TRANSPORTER 2;

ALZHEIMER DISEASE; AMINO ACID ANALYSIS; ANTIOXIDANT ACTIVITY; ASTROCYTE; BIOENERGY; BRAIN METABOLISM; BRAIN MITOCHONDRION; CENTRAL NERVOUS SYSTEM; CHOLINERGIC TRANSMISSION; DEGENERATIVE DISEASE; ENERGY METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; KETOGENESIS; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENILITY; SHORT SURVEY; SYNAPTIC TRANSMISSION;

ACETYLCARNITINE; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; CARNITINE; CHOLINE; ENERGY METABOLISM; KETONE BODIES; LIPID METABOLISM; MITOCHONDRIA; ORGANIC CATION TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 47549103898     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (45)

1. Abdul, H. M., Calabrese, V., Calvani, M. and Butterfield, D. A. (2006) Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity implications for Alzheimer's disease. J Neurosci Res, 84: 398-408.
2. Ando, S., Tadenuma, T., Tanaka, Y., Fukui, F., Kobayashi, S., Ohashi, Y. and Kawabata, T. (2001) Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res, 66: 266-271.
3. Auestad, N., Korsak, R. A., Morrow, J. W. and Edmond, J. (1991) Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem, 56: 1376-1386.
4. 0.+ in the transport of carnitine through an in vitro model of the blood-brain barrier. J Neurochem, 91: 860-872.
5. Bianchetti, A., Rozzini, R. and Trabucchi, M. (2003) Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. Curr Med Res Opin, 19: 350-353.
6. Bouzier-Sore, A. K., Serres, S., Canioni, P. and Merle, M. (2003) Lactate involvement in neuron-glia metabolic interaction: (13) C-NMR spectroscopy contribution. Biochimie, 85: 841-848.
7. Calabrese, V., Colombrita, C., Sultana, R., Scapagnini, G., Calvani, M., Butterfield, D. A. and Stella, A. M. (2006) Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: Relationship to antioxidant status and mitochondrial function. Antioxid Redox Signal, 8 (3-4): 404-416.
8. Enomoto, A., Wempe, M. F., Tsuchida, H., Shin, H. J., Cha, S. H., Anzai, N., Goto, A., Sakamoto, A., Niwa, T., Kanai, Y., Anders, M. W. and Endou, H. (2002) Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem, 277: 36262-36271.
9. Fariello, R. G. and Shug, A. L. (1981) Competitive inhibition by 3-aminopropanesulfonic acid and gamma-aminobutyric acid of carnitine transport in rat brain slices. Biochem Pharmacol, 30: 1012-1013.
10. Gründemann, D., Harlfinger, S., Golz, S., Geerts, A., Lazar, A., Berkels, R., Jung, N., Rubbert, A. and Schömig, E. (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA, 102: 5256-5261.
11. Guzman, M. and Blázquez, C. (2001) Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab, 12: 169-173.
12. Hagen, T. M., Liu, J., Lykkesfeldt, J., Wehr, C. M., Ingersoll, R. T., Vinarsky, V., Bartholomew, J. C. and Ames, B. N. (2002) Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA, 99: 1870-1875.
13. Inano, A., Sai, Y., Nikaido, H., Hashimoto, N., Asano, M., Tsuji, A. and Tamai, I. (2003) Acetyl-L-carnitine permeability across the bloodbrain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos, 24: 357-365.
14. Inazu, M., Takeda, H., Maehara, K., Miyashita, K., Tomoda, A. and Matsumiya, T. (2006) Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J Neuchochem, 97: 424-434.
15. Kido, Y., Tamai, I., Ohnari, A., Sai, Y., Kagami, T., Nezu, J., Nikaido, H., Hashimoto, N., Asano, M. and Tsuji, A. (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem, 79: 959-969.
16. Kobayashi, D., Aizawa, S., Maeda, T., Tsuboi, I., Yabuuchi, H., Nezu, J., Tsuji, A. and Tamai, I. (2004) Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. Exp Hematol, 32: 1156-1162.
17. Koepsell, H. and Endou, H. (2004) The SLC22 drug transporter family. Pflugers Arch, 447: 666-676.
18. Kuratsune, H., Yamaguti, K., Takahashi, M., Misaki, H., Tagawa, S. and Kitani, T. (1994) Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis [Suppl 1]: S62-S67.
19. Kuratsune, H., Yamaguti, K., Lindh, G., Evengård, B., Takahashi, M., Machii, T., Matsumura, K., Takaishi, J., Kawata, S., Långström, B., Kanakura, Y., Kitani, T. and Watanabe, Y. (1998) Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med, 2: 51-56.
20. Kuratsune, H., Yamaguti, K., Lindh, G., Evengård, B., Hagberg, G., Matsumura, K., Iwase, M., Onoe, H., Takahashi, M., Machii, T., Kanakura, Y., Kitani, T., Långström, B. and Watanabe, Y. (2002) Brain regions involved in fatigue sensation: Reduced acetylcarnitine uptake into the brain. Neuroimage, 17: 1256-1265.
21. Lamhonwah, A. M. and Tein, I. (2006) Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun, 345: 1315-1325.
22. Lamhonwah, A. M., Skaug, J., Scherer, S. W. and Tein, I. (2003) A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun, 301: 98-101.
23. Lamhonwah, A. M., Ackerley, C. A., Tilups, A., Edwards, V. D., Wanders, R. J. and Tein, I. (2005) OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem Biophys Res Commun, 338: 1966-1972.
24. Lamhonwah, A. M., Hawkins, C. E., Tam, C., Wong, J., Mai, L. and Tein, I. (2008) Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev, 30: 31-42.
25. Liu, J., Head, E., Gharib, A. M., Yuan, W., Ingersoll, R. T., Hagen, T. M., Cotman, C. W. and Ames, B. N. (2002) Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci USA, 99: 2356-2361.
26. Miecz, D., Januszewicz, E., Czeredys, M., Hinton, B. T., Berezowski, V., Cecchelli, R. and Nalecz, K. A. (2008) Localization of organic cation/carnitine transporter (OCTN2) in cells forming the bloodbrain barrier. J Neurochem, 104: 113-123.
27. --coupled active transport of carnitine by the amino acid transporter ATB (0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol, 532: 297-304.
28. Ohashi, R., Tamai, I., Nezu, J. I., Nikaido, H., Hashimoto, N., Oku, A., Sai, Y., Shimane, M. and Tsuji, A. (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol, 59: 358-366.
29. Pellerin, L., Bouzier-Sore, A. K., Aubert, A., Serres, S., Merle, M., Costalat, R. and Magistretti, P. J. (2007) Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia, 55: 1251-1262.
30. Pettegrew, J. W., Klunk, W. E., Panchalingam, K., Kanfer, J. N. and McClure, R. J. (1995) Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging, 16: 1-4.
31. Pettegrew, J. W., Levine, J. and McClure, R. J. (2000) Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: Rrelevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry, 5: 616-632.
32. Rai, G., Wright, G., Scott, L., Beston, B., Rest, J. and Exton-Smith, A. N. (1990) Double-blind, placebo controlled study of acetyl-1-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin, 11: 638-647.
33. Spagnoli, A., Lucca, U., Menasce, G., Bandera, L., Cizza, G., Forloni, G., Tettamanti, M., Frattura, L., Tiraboschi, P., Comelli, M., et al. (1991) Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology, 11: 1726-1732.
34. Tamai, I., Yabuchi, H., Nezu, J., Sai, Y., Oku, A., Shimane, M. and Tsuji, A. (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett, 419: 107-111.
35. Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y. and Tsuji, A. (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem, 273: 20378-20382.
36. Tamai, I., Ohashi, R., Nezu, J. I., Sai, Y., Kobayashi, D., Oku, A., Shimane, M. and Tsuji, A. (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem, 275: 40064-40072.
37. Thal, L. J., Carta, A., Clarke, W. R., Ferris, S. H., Friedland, R. P., Petersen, R. C., Pettegrew, J. W., Pfeiffer, E., Raskind, M. A., Sano, M., Tuszynski, M. H. and Woolson, R. F. (1996) A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology, 47: 705-711.
38. Wawrzeńczyk, A., Nałecz, K. A. and Nałecz, M. J. (1995) Effect of gamma-aminobutyric acid on the carnitine metabolism in neural cells. Biochem Biophys Res Commun, 213: 383-388.
39. Wawrzeńczyk, A., Sacher, A., Mac, M., Nałecz, M. J. and Nałecz, K. A. (2001) Transport of L-carnitine in isolated cerebral cortex neurons. Eur J Biochem, 268: 2091 2098.
40. White, H. L. and States, P. W. (1990) Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem Res, 15: 597-601.
41. Wolfgang, M. J., Kurama, T., Dai, Y., Suwa, A., Asaumi, M., Matsumoto, S., Cha, S. H., Shimokawa, T. and Lane, M. D. (2006) The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA, 103: 7282-7287.
42. Wolfgang, M. J., Cha, S. H., Millington, D. S., Cline, G., Shulman, G. I., Suwa, A., Asaumi M., Kurama, T., Shimokawa, T. and Lane, M. D. (2008) Brain-specific carnitine palmitoyltransferase-1c: Role in CNS fatty acid metabolism, food intake and body weight. J Neurochem, online accepted article. doi: 10.1111/j.1471-4159. 2008.05225.x
43. Wu, X., Huang, W., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J. and Ganapathy, V. (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther, 290: 1482-1492.
44. Xuan, W., Lamhonwah, A. M., Librach, C., Jarvi, K. and Tein, I. (2003) Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun, 306: 121-128.
45. Zoccarato, F., Siliprandi, N. and Rugolo, M. (1983) Studies on the transport of carnitine in the brain using synaptosomes isolated from guinea-pig cerebral cortex. Biochim Biophys Acta, 734: 381-383.